Fingolimod in a patient with Wolff–Parkinson

Abstract

Get full access to this article

View all access options for this article.

References

Cohen

Chun

. Mechanisms of fingolimod’s efficacy and adverse effects in multiple sclerosis. Ann Neurol 2011; 69: 759–777.

Lindsey

Haden-Pinneri

Memon

. Sudden unexpected death on fingolimod. Mult Scler 2012; 18: 1507–1508.

Faber

Fischer

Weber

. Prolonged and symptomatic bradycardia following a single dose of fingolimod. Mult Scler 2013; 19: 126–128.

Espinosa

Berger

. Delayed fingolimod-associated asystole. Mult Scler 2011; 17: 1387–1389.

Svendsen

Dagres

Dobreanu

. Current strategy for treatment of patients with Wolff–Parkinson–White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey. Europace 2013; 15: 750–753.

Fingolimod in a patient with Wolff–Parkinson–White syndrome

Abstract

Get full access to this article

References